Bellwether Advisors LLC Has $2.51 Million Stock Position in Humana Inc. (NYSE:HUM)

Bellwether Advisors LLC boosted its stake in Humana Inc. (NYSE:HUMFree Report) by 19.3% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 6,723 shares of the insurance provider’s stock after buying an additional 1,089 shares during the period. Bellwether Advisors LLC’s holdings in Humana were worth $2,512,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Waldron Private Wealth LLC bought a new position in shares of Humana during the second quarter valued at $297,000. Summit Financial LLC bought a new position in shares of Humana during the second quarter valued at $284,000. Farther Finance Advisors LLC raised its stake in shares of Humana by 8.0% during the second quarter. Farther Finance Advisors LLC now owns 2,028 shares of the insurance provider’s stock valued at $758,000 after acquiring an additional 151 shares during the last quarter. Graypoint LLC raised its stake in Humana by 71.0% during the second quarter. Graypoint LLC now owns 1,069 shares of the insurance provider’s stock worth $400,000 after buying an additional 444 shares during the last quarter. Finally, Sage Mountain Advisors LLC bought a new position in Humana during the second quarter worth $249,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on HUM shares. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. TD Cowen lifted their target price on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Oppenheimer lifted their target price on shares of Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a research note on Thursday, August 1st. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 target price on shares of Humana in a research note on Monday, August 19th. Finally, JPMorgan Chase & Co. raised their price target on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $396.35.

View Our Latest Stock Report on HUM

Humana Trading Up 0.9 %

Shares of Humana stock traded up $3.11 during trading on Friday, reaching $354.47. The company’s stock had a trading volume of 1,135,132 shares, compared to its average volume of 800,611. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a market cap of $42.68 billion, a price-to-earnings ratio of 22.07, a PEG ratio of 3.16 and a beta of 0.51. The firm’s 50-day moving average is $367.67 and its two-hundred day moving average is $346.86. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company had revenue of $29.54 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same period in the prior year, the business posted $8.94 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is presently 22.04%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.